Bull
$35.25
Scenario price
$29.040
-0.749 (-2.58%)At close
Gentherm Incorporated is a provider of thermal and precision flow management technologies. The Automotive reporting segment comprises global automotive businesses, including the design, development, manufacturing and sales of its automotive climate and comfort solutions (including Climate Control Seats, Climate Control Interiors, and others), Valve Systems and other automotive products. The Medical reporting segment comprises the patient temperature management business in the medical industry. Patient temperature management includes temperature management systems across multiple product categories addressing the needs of hyper-hypothermia therapy in intensive care, normothermia in surgical procedures and additional warming/cooling therapies utilized in acute and chronic care departments and non-hospital facilities. It also offers highly engineered, mission-critical thermal solutions serving commercial vehicles, off-highway equipment, light vehicle and power generation markets.
Gentherm Inc (THRM) is currently trading at $29.68, which is significantly below analyst price targets of $48 and $50, indicating potential upside. However, the RSI is at a low 19.91, suggesting the stock is oversold, but this could also indicate continued weakness. The company has shown a year-to-date decline of 19.41%, and hedge funds are selling, with a 8556.93% increase in selling activity over the last quarter, which raises concerns about short-term performance. Therefore, while there is potential for recovery, the current market sentiment and technical indicators suggest holding rather than buying at this time.
JPMorgan
$48
2026-09-15
JPMorgan
2026-09-15
Price Target
$48
CJS Securities
$50
2026-09-14
CJS Securities
2026-09-14
Price Target
$50
Roth Capital
$50
2026-07-29
Roth Capital
2026-07-29
Price Target
$50
Freedom Broker
$40
2026-07-24
Freedom Broker
2026-07-24
Price Target
$40
JPMorgan
$48
2026-07-24
JPMorgan
2026-07-24
Price Target
$48
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

Modine Completes Spin-Off and Merger with Gentherm

Gentherm Shareholders Approve Merger with Modine

Gentherm (THRM) Q2 2026 Earnings Call Transcript

Robinhood and Gentherm Options Trading Activity Surges

Gentherm Raises 2026 Guidance Following Strong Q2 Performance
Gentherm Incorporated is a provider of thermal and precision flow management technologies. The Automotive reporting segment comprises global automotive businesses, including the design, development, manufacturing and sales of its automotive climate and comfort solutions (including Climate Control Seats, Climate Control Interiors, and others), Valve Systems and other automotive products. The Medical reporting segment comprises the patient temperature management business in the medical industry. Patient temperature management includes temperature management systems across multiple product categories addressing the needs of hyper-hypothermia therapy in intensive care, normothermia in surgical procedures and additional warming/cooling therapies utilized in acute and chronic care departments and non-hospital facilities. It also offers highly engineered, mission-critical thermal solutions serving commercial vehicles, off-highway equipment, light vehicle and power generation markets. It operates in the Consumer Cyclicals sector (MOTOR VEHICLE PARTS & ACCESSORIES industry).
Gentherm Inc (THRM) is currently trading at $29.68, which is significantly below analyst price targets of $48 and $50, indicating potential upside. However, the RSI is at a low 19.91, suggesting the stock is oversold, but this could also indicate continued weakness. The company has shown a year-to-date decline of 19.41%, and hedge funds are selling, with a 8556.93% increase in selling activity over the last quarter, which raises concerns about short-term performance. Therefore, while there is potential for recovery, the current market sentiment and technical indicators suggest holding rather than buying at this time.
9 analysts cover THRM: 5 rate it Buy, 4 Hold and 0 Sell. The average price target is 43.33.
No posts yet
Sign up or log in to join the discussionThis page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.